ULIPRISTAL ACETATE (Esmya ®)

Clinical Indication

Uterine fibroids

Comments

In line with MHRA alert March 2020 regarding risks of liver injury.

Date of classification

February 2019

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.